JACOBS LEVY EQUITY MANAGEMENT, INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2022$528,000
-25.1%
556,214
-5.3%
0.00%
-20.0%
Q2 2022$705,000
-62.4%
587,645
-58.9%
0.01%
-61.5%
Q1 2022$1,874,000
+4.6%
1,430,252
+40.5%
0.01%
+8.3%
Q4 2021$1,791,000
+491.1%
1,017,746
+629.0%
0.01%
+500.0%
Q3 2021$303,000
-69.5%
139,604
+44.6%
0.00%
-80.0%
Q3 2020$994,000
-55.4%
96,544
-9.5%
0.01%
-58.3%
Q2 2020$2,228,000
+72.3%
106,693
-19.4%
0.02%
+41.2%
Q1 2020$1,293,000
-9.8%
132,297
+6.3%
0.02%
+21.4%
Q4 2019$1,434,000
+396.2%
124,440
+134.8%
0.01%
+250.0%
Q3 2019$289,000
-23.5%
53,000
+66.7%
0.00%
-20.0%
Q2 2019$378,000
+65.8%
31,800
-27.1%
0.01%
+66.7%
Q1 2019$228,000
-27.2%
43,600
-56.1%
0.00%
-50.0%
Q4 2018$313,000
-14.2%
99,333
+64.8%
0.01%
+20.0%
Q3 2018$365,000
-16.9%
60,291
-27.1%
0.01%
-28.6%
Q2 2018$439,000
+8.4%
82,754
+18.4%
0.01%0.0%
Q1 2018$405,000
+30.6%
69,891
-21.1%
0.01%
+40.0%
Q4 2017$310,000
-7.5%
88,591
-3.4%
0.01%
-28.6%
Q3 2017$335,000
+63.4%
91,691
+11.8%
0.01%
+75.0%
Q2 2017$205,000
+210.6%
81,991
+235.4%
0.00%
+300.0%
Q1 2017$66,00024,4470.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders